Dr. Teesalu is a visiting professor in the Ruoslahti laboratory at the Center for Nanomedicine and Sanford Burnham Prebys Medical Discovery Institute on the UC Santa Barbara campus. Dr. Teesalu is the head of the Lab of Cancer Biology (www.cancerbiology.ee ) of the Institute of Biomedicine and Translational Medicine of the University of Tartu (Estonia, EU) and adjunct assistant professor at the Sanford Burnham Prebys Medical Discovery Institute in La Jolla (CA).
Dr. Teesalu received his Ph.D. from the University of Helsinki, Finland in 1999. He uses phage display screens to identify homing peptides that bind to specific targets in the vasculature. Corresponding synthetic peptides are explored for targeting drugs, biological, and nanoparticles into tumors to increase their therapeutic index. His scope includes understanding the molecular interactions involved to drive specificity and activity, focusing on Tumor Penetrating Peptides (TPP) that trigger bulk extravascular transport in the tumor tissue.